Cargando…
Guideline- Versus Non-Guideline-Based Neoadjuvant Management of Clinical T4 Rectal Cancer
(1) Background: Practice guidelines recommend neoadjuvant treatment for clinical T4 rectal cancer. The primary objective of this retrospective study was to assess whether compliance with guidelines correlates with patient outcomes. Secondarily, we evaluated predictors of adherence to guidelines and...
Autores principales: | Chen, Xi, Xie, Xinyu, Wang, Xiaodong, Wei, Mingtian, Li, Zhigui, Li, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605917/ https://www.ncbi.nlm.nih.gov/pubmed/37887576 http://dx.doi.org/10.3390/curroncol30100676 |
Ejemplares similares
-
Comparison of guidelines for the management of rectal cancer
por: Luzietti, E., et al.
Publicado: (2018) -
SEOM Clinical Guideline of localized rectal cancer (2016)
por: González-Flores, E., et al.
Publicado: (2016) -
Can neoadjuvant chemoradiotherapy combined with immunotherapy benefit patients with microsatellite stable locally advanced rectal cancer? a pooled and integration analysis
por: Yue, Yumin, et al.
Publicado: (2023) -
Management of colon and rectal cancers during COVID-19 pandemic: A clinical guideline (TUMS-CRC-CoV19 Guideline)
por: Keramati, Mohammad Reza, et al.
Publicado: (2020) -
Should Local Excision After Neoadjuvant Therapy Be Included in the National Guidelines for the Treatment of Locally Advanced Rectal Cancer?
por: Aref, Amr, et al.
Publicado: (2022)